Role of Shatpushpa oil nasya in Raktapradar along with kutajashtak churn.

To study the effect of kutajashtak churn with and without nasya of shatpushpa oil in Raktapradar. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093944

Enrollment

Registered

2025-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Total 50 patients will be devided into two groups, Group A and B.25 patients in each group

Exclusion criteria

Exclusion criteria: 1.Uterine tumors 2.enometriosis 3.carcinoma 4.diabetes 5.hypertension 6. Venous thrombosis 7. Sub involution 8. Infection like Pelvic cellulitis,peritonitis, endometriosis 9. Displacement like genital prolapse and retroversion 10. Developmental errors of uterus like septus uterus 11.local injury IUCD 12. Pregnancy states (abortion, hydatiform mole, ectopic pregnancy) 13.acute pyrexial illness 14. Disease of CVS like reduced number of platelets, severe anemia, thrombocytopenia purpura, hemoglobinopathies

Design outcomes

Primary

Measure	Time frame
Reduction in Raktapradar (Abnormal Uterine Bleeding) Measured through:90days Frequency and duration of bleeding episodes (menstrual cycles) Hemoglobin level improvement (g/dL) Timepoint: 90 days	—

Secondary

Measure	Time frame
Relief in associated symptomsTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Manisha Sagore

Govt Dhanwantari ayurved medical college and hospital Ujjain

ssathua8@gmail.com075665 14077

Outcome results